Impact of chemotherapy on gastrointestinal functions and the enteric nervous system

被引:49
作者
Escalante, Jonathan [1 ]
McQuade, Rachel M. [1 ]
Stojanovska, Vanesa [1 ]
Nurgali, Kulmira [1 ]
机构
[1] Victoria Univ, Sunshine Hosp, Western Ctr Hlth Res & Educ, Coll Hlth & Biomed, St Albans, Vic 3021, Australia
关键词
Enteric neuropathy; Chemotherapy; Chemotherapy-induced constipation; Chemotherapy-induced diarrhea; ADVANCED COLORECTAL-CANCER; NITRIC-OXIDE SYNTHASE; MYENTERIC AH NEURONS; INDUCED MUCOSITIS; MECHANISMS; OXALIPLATIN; IRINOTECAN; CONSTIPATION; MANAGEMENT; 5-FLUOROURACIL;
D O I
10.1016/j.maturitas.2017.04.021
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Chemotherapy is the main treatment for many cancers, including colorectal cancer, a type of cancer with some of the highest prevalence and mortality rates Worldwide. Although chemotherapeutic drugs have greatly improved the survival rates of cancer patients, there are many side-effects associated with their use. The gastrointestinal side-effects of chemotherapy often lead to dose reduction or even discontinuation of treatment, which in turn affects the clinical outcome. Gastrointestinal side-effects, such as chemotherapy-induced diarrhea and constipation, may persist many years after treatment, greatly reducing quality of life. Current treatments for these side effects have many adverse effects themselves; therefore, new approaches are needed to address this problem. Changes in the enteric nervous system located within the gastrointestinal tract and controlling its functions have been implicated in many disorders. Recent studies providing insight into the association between chemotherapy induced damage to enteric neurons and gastrointestinal dysfunction have highlighted the enteric nervous system as a potential therapeutic target to alleviate chemotherapy-induced toxicity which may improve both clinical outcomes and the quality of patients' lives.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 125 条
[41]   Chemotherapy-induced gut toxicity and pain: involvement of TLRs [J].
Gibson, Rachel J. ;
Coller, Janet K. ;
Wardill, Hannah R. ;
Hutchinson, Mark R. ;
Smid, Scott ;
Bowen, Joanne M. .
SUPPORTIVE CARE IN CANCER, 2016, 24 (05) :2251-2258
[42]   Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer [J].
Gibson, RJ ;
Bowen, JM ;
Inglis, MRB ;
Cummins, AG ;
Keefe, DMK .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (09) :1095-1100
[43]   Modifiable risk factors for colon cancer [J].
Giovannucci, E .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (04) :925-+
[44]   Advances in the treatment of metastatic colorectal cancer [J].
Goldberg, RM .
ONCOLOGIST, 2005, 10 :40-48
[45]   Building a brain in the gut: development of the enteric nervous system [J].
Goldstein, A. M. ;
Hofstra, R. M. W. ;
Burns, A. J. .
CLINICAL GENETICS, 2013, 83 (04) :307-316
[46]   Changes in DNA repair during aging [J].
Gorbunova, Vera ;
Seluanov, Andrei ;
Mao, Zhiyong ;
Hine, Christpher .
NUCLEIC ACIDS RESEARCH, 2007, 35 (22) :7466-7474
[47]  
Graham MA, 2000, CLIN CANCER RES, V6, P1205
[48]   Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment [J].
Grothey, A ;
Sargent, D ;
Goldberg, RM ;
Schmoll, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1209-1214
[49]   Segmentation induced by intraluminal fatty acid in isolated guinea-pig duodenum and jejunum [J].
Gwynne, RM ;
Thomas, EA ;
Goh, SM ;
Sjövall, H ;
Bornstein, JC .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 556 (02) :557-569
[50]   The enteric nervous system II: Gastrointestinal functions [J].
Hansen, MB .
PHARMACOLOGY & TOXICOLOGY, 2003, 92 (06) :249-257